Dover Advisors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.2M | Buy |
1,533
+32
| +2% | +$24.9K | 0.53% | 51 |
|
|
2025
Q1 | $1.24M | Sell |
1,501
-33
| -2% | -$27.3K | 0.54% | 52 |
|
|
2024
Q4 | $1.18M | Hold |
1,534
| – | – | 0.68% | 50 |
|
|
2024
Q3 | $1.36M | Sell |
1,534
-13
| -0.8% | -$11.5K | 0.77% | 42 |
|
|
2024
Q2 | $1.4M | Sell |
1,547
-18
| -1% | -$16.3K | 0.87% | 36 |
|
|
2024
Q1 | $1.22M | Buy |
1,565
+120
| +8% | +$93.4K | 0.83% | 38 |
|
|
2023
Q4 | $842K | Sell |
1,445
-388
| -21% | -$226K | 1.11% | 31 |
|
|
2023
Q3 | $985K | Sell |
1,833
-8
| -0.4% | -$4.3K | 1% | 35 |
|
|
2023
Q2 | $863K | Sell |
1,841
-336
| -15% | -$158K | 0.77% | 44 |
|
|
2023
Q1 | $748K | Buy |
2,177
+340
| +19% | +$117K | 0.72% | 48 |
|
|
2022
Q4 | $672K | Buy |
+1,837
| New | +$672K | 0.72% | 49 |
|